Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis

This study has been completed.
Information provided by:
University of Cincinnati
ClinicalTrials.gov Identifier:
First received: April 3, 2009
Last updated: NA
Last verified: April 2009
History: No changes posted
The study hypothesis is that a quantitative index can be derived from Tc-99m myocardial perfusion scans that accurately identifies the presence of left ventricular hypertrophy and pulmonary hypertension. Echocardiography provides the reference standard.

Condition Intervention
Pulmonary Hypertension
Other: Diagnostic imaging procedures.

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis Between Tc-99m Tetrofosmin SPECT Adn Echocardiography

Resource links provided by NLM:

Further study details as provided by University of Cincinnati:

Primary Outcome Measures:
  • Sensitivity and specificity of quantitation of Tc-99m perfusion scans for identification of pulmonary hypertension. [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Study Start Date: February 2008
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Group 1
Patients having both Tc-99m perfusion scan and echocardiogram.
Other: Diagnostic imaging procedures.


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Hospital population having diagnostic testing.

Inclusion Criteria:

  • Must have an interpretable Tc-99m myocardial perfusion scan and an interpretable echocardiogram.

Exclusion Criteria:

  • Technically inadequate noninvasive test.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00875940

United States, Ohio
University of Cincinnati
Cincinnati, Ohio, United States, 45267
Sponsors and Collaborators
University of Cincinnati
  More Information

Responsible Party: Myron Gerson M.D., University Internal Medicine Associates
ClinicalTrials.gov Identifier: NCT00875940     History of Changes
Other Study ID Numbers: IRB # 08-01-24-02 
Study First Received: April 3, 2009
Last Updated: April 3, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hypertension, Pulmonary
Hypertrophy, Right Ventricular
Cardiovascular Diseases
Heart Diseases
Lung Diseases
Pathological Conditions, Anatomical
Respiratory Tract Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 25, 2016